CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 100 enrolled
Drug / intervention
Self-collection +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02431520
NCT02431520N/ACompleted
CompareCT.gov

Patient Compliance to Self-collection for Detection of HPV-DNA in Cervical Cancer Prevention: A Clinical Trial

Oswaldo Cruz Foundation·interventional·Posted May 1, 2015·Updated May 6, 2015

In Brief

A clinical study evaluating Self-collection and Gynecologist collection for Compliance and Cervical Cancer. Completed, enrolled 100 participants across 1 site.

Detailed Summary

A study to investigate the compliance of unassisted women to self-collection of specimens for Hybrid Capture (HC) for detection of Human Papilloma Virus (HPV) DNA compared to Pap smear collection by medical personnel, as screening method to identify precursor lesions of cervical cancer.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCompliance, Cervical Cancer
CountriesBrazil
CollaboratorsCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 1, 2015
Enrollment StartMay 1, 2007
Primary CompletionSep 1, 2007
Study CompletionDec 1, 2007
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 11.2 years ago

Interventions

Self-collectionprocedure

Women allocated to this arm will be asked to obtain a specimen of vaginal/cervical by self-collection for HCII.

Gynecologist collectionprocedure

Women allocated to this arm will be asked to attend to medical office to have their Pap smear obtained by a gynecologist